IP Library › Granted Patent US 8,569,503
Granted Patent B2
US 8,569,503 · App. 13/330,959 · Granted Oct 29, 2013

Processes and intermediates for preparing fused heterocyclic kinase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,569,503
App. No.
13/330,959
Granted
Oct 29, 2013
Kind
B2
Abstract

This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.

Claims (1)

1. A compound having the structure:

Assignments (2)
CHANGE OF NAME Recorded Oct 19, 2022
From: METHYLGENE INC.
To: METHYLGENE ULC
Reel/Frame 061470/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2022
From: METHYLGENE ULC
To: MIRATI THERAPEUTICS, INC.
Reel/Frame 061470/0650 →